Osteomyelitis: Difference between revisions
From IDWiki
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
* |
*See also: |
||
** |
**[[Acute osteomyelitis]] |
||
** |
**[[Chronic osteomyelitis]] |
||
== |
==Management== |
||
* |
*No clinically meaningful differences in bone penetration between classes of antibiotics exist[[CiteRef::landersdorfer2009pe]] |
||
* |
*Bioavailability likely still important |
||
[[Category:Bone and joint infections]] |
[[Category:Bone and joint infections]] |
Revision as of 18:44, 18 September 2020
- See also:
Management
- No clinically meaningful differences in bone penetration between classes of antibiotics exist1
- Bioavailability likely still important
References
- ^ Elysia A. Masters, Benjamin F. Ricciardi, Karen L. de Mesy Bentley, T. Fintan Moriarty, Edward M. Schwarz, Gowrishankar Muthukrishnan. Skeletal infections: microbial pathogenesis, immunity and clinical management. Nature Reviews Microbiology. 2022. doi:10.1038/s41579-022-00686-0.
- ^ Cornelia B. Landersdorfer, Jürgen B. Bulitta, Martina Kinzig, Ulrike Holzgrabe, Fritz Sörgel. Penetration of Antibacterials into Bone. Clinical Pharmacokinetics. 2009;48(2):89-124. doi:10.2165/00003088-200948020-00002.